Literature DB >> 22111971

Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children.

P E Pardee1, W Dunn, J B Schwimmer.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in children. Liver disease can be a cause of low bone mineral density. Whether or not NAFLD influences bone health is not known. AIM: To evaluate bone mineral density in obese children with and without NAFLD.
METHODS: Thirty-eight children with biopsy-proven NAFLD were matched for age, gender, race, ethnicity, height and weight to children without evidence of liver disease from the National Health and Nutrition Examination Survey. Bone mineral density was measured by dual energy X-ray absorptiometry. Age and gender-specific bone mineral density Z-scores were calculated and compared between children with and without NAFLD. After controlling for age, gender, race, ethnicity and total per cent body fat, the relationship between bone mineral density and the severity of histology was analysed in children with NAFLD.
RESULTS: Obese children with NAFLD had significantly (P < 0.0001) lower bone mineral density Z-scores (-1.98) than obese children without NAFLD (0.48). Forty-five per cent of children with NAFLD had low-bone mineral density for age, compared to none of the children without NAFLD (P < 0.0001). Among those children with NAFLD, children with NASH had a significantly (P < 0.05) lower bone mineral density Z-score (-2.37) than children with NAFLD who did not have NASH (-1.58).
CONCLUSIONS: The NAFLD was associated with poor bone health in obese children. More severe disease was associated with lower bone mineralisation. Further studies are needed to evaluate the underlying mechanisms and consequences of poor bone mineralisation in children with NAFLD.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22111971      PMCID: PMC4624396          DOI: 10.1111/j.1365-2036.2011.04924.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  41 in total

1.  Comparison of two software versions for assessment of body-composition analysis by DXA.

Authors:  B Vozarova; J Wang; C Weyer; P A Tataranni
Journal:  Obes Res       Date:  2001-03

2.  Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation.

Authors:  Osami Kudo; Yosuke Fujikawa; Ichiro Itonaga; Afsie Sabokbar; Takehiko Torisu; Nicholas A Athanasou
Journal:  J Pathol       Date:  2002-10       Impact factor: 7.996

3.  Association of lean tissue and fat mass with bone mineral content in children and adolescents.

Authors:  Angelo Pietrobelli; Myles S Faith; Jack Wang; Paolo Brambilla; Giuseppe Chiumello; Steven B Heymsfield
Journal:  Obes Res       Date:  2002-01

4.  Undetected hepatomegaly in obese children by primary care physicians: a pitfall in the diagnosis of pediatric nonalcoholic fatty liver disease.

Authors:  Mark Fishbein; Jennifer Mogren; Chris Mogren; Sibyl Cox; Ryan Jennings
Journal:  Clin Pediatr (Phila)       Date:  2005-03       Impact factor: 1.168

5.  Visceral fat is a negative predictor of bone density measures in obese adolescent girls.

Authors:  Melissa Russell; Nara Mendes; Karen K Miller; Clifford J Rosen; Hang Lee; Anne Klibanski; Madhusmita Misra
Journal:  J Clin Endocrinol Metab       Date:  2010-01-15       Impact factor: 5.958

6.  Peak bone mineral density, lean body mass and fractures.

Authors:  Annemieke M Boot; Maria A J de Ridder; Inge M van der Sluis; Ingrid van Slobbe; Eric P Krenning; Sabine M P F de Muinck Keizer-Schrama
Journal:  Bone       Date:  2009-10-13       Impact factor: 4.398

7.  Steatohepatitis in obese children: a cause of chronic liver dysfunction.

Authors:  J R Moran; F K Ghishan; S A Halter; H L Greene
Journal:  Am J Gastroenterol       Date:  1983-06       Impact factor: 10.864

8.  Bone structure and volumetric BMD in overweight children: a longitudinal study.

Authors:  Rachel J Wetzsteon; Moira A Petit; Heather M Macdonald; Julie M Hughes; Thomas J Beck; Heather A McKay
Journal:  J Bone Miner Res       Date:  2008-12       Impact factor: 6.741

Review 9.  Bone disorders in chronic liver disease.

Authors:  Jane Collier
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

10.  SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease.

Authors:  Jeffrey B Schwimmer; Winston Dunn; Gregory J Norman; Perrie E Pardee; Michael S Middleton; Nanda Kerkar; Claude B Sirlin
Journal:  Gastroenterology       Date:  2010-01-11       Impact factor: 22.682

View more
  39 in total

Review 1.  Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?

Authors:  G Targher; A Lonardo; M Rossini
Journal:  J Endocrinol Invest       Date:  2015-05-24       Impact factor: 4.256

2.  Nonalcoholic Fatty Liver Disease and Bone Mineral Density in Children and Adolescents: Specific Considerations for Future Studies.

Authors:  Alessandro Mantovani
Journal:  Dig Dis Sci       Date:  2018-11-14       Impact factor: 3.199

3.  Non-alcoholic fatty liver, adipose tissue, and the bone: a new triumvirate on the block.

Authors:  Giovanni Musso
Journal:  Endocrine       Date:  2012-07-18       Impact factor: 3.633

Review 4.  Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis.

Authors:  Sikarin Upala; Veeravich Jaruvongvanich; Karn Wijarnpreecha; Anawin Sanguankeo
Journal:  J Bone Miner Metab       Date:  2016-12-07       Impact factor: 2.626

5.  Bone marrow fat content is correlated with hepatic fat content in paediatric non-alcoholic fatty liver disease.

Authors:  N Y Yu; T Wolfson; M S Middleton; G Hamilton; A Gamst; J E Angeles; J B Schwimmer; C B Sirlin
Journal:  Clin Radiol       Date:  2017-01-05       Impact factor: 2.350

6.  Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease.

Authors:  Stergios A Polyzos; Athanasios D Anastasilakis; Jannis Kountouras; Polyzois Makras; Athanasios Papatheodorou; Panagiotis Kokkoris; Grigorios T Sakellariou; Evangelos Terpos
Journal:  J Bone Miner Metab       Date:  2015-06-09       Impact factor: 2.626

7.  Reduced Serum IGF-1 Associated With Hepatic Osteodystrophy Is a Main Determinant of Low Cortical but Not Trabecular Bone Mass.

Authors:  Zhongbo Liu; Tianzhen Han; Haim Werner; Clifford J Rosen; Mitchell B Schaffler; Shoshana Yakar
Journal:  J Bone Miner Res       Date:  2017-11-06       Impact factor: 6.741

Review 8.  Endocrine causes of nonalcoholic fatty liver disease.

Authors:  Laura Marino; François R Jornayvaz
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

9.  Pediatric Nonalcoholic Fatty Liver Disease: A Report from the Expert Committee on Nonalcoholic Fatty Liver Disease (ECON).

Authors:  Rohit Kohli; Shikha Sunduram; Marialena Mouzaki; Sabina Ali; Pushpa Sathya; Stephanie Abrams; Stavra A Xanthakos; Miriam Vos; Jeffrey B Schwimmer
Journal:  J Pediatr       Date:  2016-01-01       Impact factor: 4.406

Review 10.  The Progression and Natural History of Pediatric Nonalcoholic Fatty Liver Disease.

Authors:  Nidhi P Goyal; Jeffrey B Schwimmer
Journal:  Clin Liver Dis       Date:  2015-12-14       Impact factor: 6.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.